nach oben

15.05.2024 | Case Study

Intraoperative radiation therapy for brain metastasis in a pregnant patient: a case report

verfasst von: Dr. med. K. P. Aninditha, S. Baumbach, T. Ellethy, G. Klumpp, A. Golle, S. Kuhn, N. Wegner, O. Ganslandt, M. W. Münter

Erschienen in: Strahlentherapie und Onkologie

Einloggen, um Zugang zu erhalten

Abstract

We present the rare case of a 42-year-old woman with oligometastatic lung adenocarcinoma in her first trimester of pregnancy who was treated for brain metastases with metastasectomy and intraoperative radiation therapy (IORT) using the INTRABEAM® system (Zeiss AG, Jena, Germany). This case underscores the potential of IORT in optimizing cancer treatment while safeguarding fetal health in pregnant patients.

Proskynitopoulos PJ, Lam FC, Sharma S, Young BC, Laviv Y, Kasper EM (2021) A Review of the Neurosurgical Management of Brain Metastases during Pregnancy. Can J Neurol Sci. https://doi.org/10.1017/cjn.2020.254CrossRefPubMed

Verheecke M, Halaska MJ, Lok CA et al (2014) Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review of literature. Eur J Cancer. https://doi.org/10.1016/j.ejca.2014.02.018CrossRefPubMed

Gatson NTN (2022) Managing central nervous system tumors during pregnancy. continuum Lifelong Learn Neurol. https://doi.org/10.1212/CON.0000000000001107CrossRef

Vogelbaum MA, Brown PD, Messersmith H et al (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40(5):492–516. https://doi.org/10.1200/JCO.21.02314CrossRefPubMed

Deutsche Gesellschaft für Medizinische Physik e. V. Pränatale Strahlenexposition Aus Medizinischer Indikation: Dosisermittlung, Folgerungen Für die Ärztin/den Arzt Und Schwangere. DGMP-Bericht Nr. 7.; 2019. www.dgmp.de

Kahl KH, Balagiannis N, Höck M et al (2021) Intraoperative radiotherapy with low-energy x‑rays after neurosurgical resection of brain metastases—an Augsburg University Medical Center experience. Strahlenther Onkol. https://doi.org/10.1007/s00066-021-01831-zCrossRefPubMedPubMedCentral

Cifarelli CP, Brehmer S, Vargo JA et al (2019) Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study. J Neurooncol. https://doi.org/10.1007/s11060-019-03309-6CrossRefPubMedPubMedCentral

Cifarelli C, Vargo JA, Hack J et al (2019) RADI-20. Retrospective outcome analysis of intraoperative radiotherapy (IORT) for surgically resected brain metastases: an international cooperative study. Neurooncol Adv. https://doi.org/10.1093/noajnl/vdz014.112CrossRefPubMedCentral

Diehl CD, Pigorsch SU, Gempt J et al (2023) Low-energy X‑Ray Intraoperative radiation therapy (lex-IORT) for resected brain metastases: a single-institution experience. Cancers. https://doi.org/10.3390/cancers15010014CrossRefPubMedPubMedCentral

10.

Dahshan BA, Weir JS, Bice RP et al (2021) Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: comparison of IORT, SRS, and IMRT indices. Brachytherapy. https://doi.org/10.1016/j.brachy.2020.11.004CrossRefPubMedPubMedCentral

11.

Spigel DR, Faivre-Finn C, Gray JE et al (2022) Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. J Clin Oncol 40(12):1301–1311. https://doi.org/10.1200/JCO.21.01308CrossRefPubMedPubMedCentral

12.

Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141CrossRefPubMed

13.

Brown PD, Ballman KV, Cerhan JH et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1049–1060. https://doi.org/10.1016/S1470-2045(17)30441-2CrossRefPubMedPubMedCentral

14.

Patchell R, Tibbs P, Regine W et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489CrossRefPubMed

15.

Hamed M, Potthoff AL, Layer JP et al (2022) Benchmarking safety indicators of surgical treatment of brain metastases combined with intraoperative radiotherapy: results of prospective observational study with comparative matched-pair analysis. Cancers. https://doi.org/10.3390/cancers14061515CrossRefPubMedPubMedCentral

16.

Geng C, Moteabbed M, Seco J et al (2016) Dose assessment for the fetus considering scattered and secondary radiation from photon and proton therapy when treating a brain tumor of the mother. Phys Med Biol 61(2):683–695. https://doi.org/10.1088/0031-9155/61/2/683CrossRefPubMed

17.

Pantelis E, Antypas C, Frassanito MC et al (2016) Radiation dose to the fetus during cyberknife radiosurgery for a brain tumor in pregnancy. Phys Med 32(1):237–241. https://doi.org/10.1016/J.EJMP.2015.09.014CrossRefPubMed

Titel: Intraoperative radiation therapy for brain metastasis in a pregnant patient: a case report
verfasst von: Dr. med. K. P. Aninditha
S. Baumbach
T. Ellethy
G. Klumpp
A. Golle
S. Kuhn
N. Wegner
O. Ganslandt
M. W. Münter
Publikationsdatum: 15.05.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Strahlentherapie und Onkologie
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-024-02239-1

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Intraoperative radiation therapy for brain metastasis in a pregnant patient: a case report

Abstract

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie